clinical trial · NCT04860635
Safety of F14 Following Total Knee Replacement
Arthritis Innovation Corporation·phase3·suspended·n = 100
AnalgesiaF14 (sustained release celecoxib)
brief summary
Open-label single-arm study in which all subjects receive F14 as part of a scheduled TKR and multimodal analgesia
started
Sep 1, 2026
primary completion
Apr 1, 2028
completion
Apr 1, 2028
last updated
Nov 26, 2025
official title
An Open Label Safety Study of a Single Administration of F14 in Patients Undergoing Unilateral Total Knee Replacement
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol